Nasus Pharma Ltd (NSRX) stock
NSRXNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 25, 2026Score 6/30
$2.70+0.09 (+3.45%)
Close on Nov 18, 2026Market cap $24.34MP/E –Yield –
Nasus Pharma operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was -$4.92M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$4.92M | – |
| FY2024 | Dec 31, 2024 | -$665.00K | – |
| FY2023 | Dec 31, 2023 | -$1.03M | – |
See a number that looks wrong?